According to the current analysis
of Reports and Data, the global Bioprosthetics
market was valued at USD 3.32 billion in 2018 and is expected to reach
USD 7.38 billion by year 2026, at a CAGR of 10.4%. The use of Bioprosthetics
has significantly increased over the recent years in all age groups. The study
provides an overall insight into the factors responsible for the growth in the
Bioprosthetics market. Two major types of prosthetic heart valves exist
mechanical and bio prosthetic. Bioprosthetics are made of biologic tissues
which are mounted on a fabric covered plastic frame, called a stent.
Valvular heart disease is
increasingly affecting more than 100 million people worldwide and is a growing
problem because of the high incidence of rheumatic heart disease. Moreover, in
developing countries, the burden of degenerative valve disease in ageing
population is increasing due to the rising geriatric population. Extensive
growth in population and increasing prevalence of cardiovascular diseases owing
to the unhealthy lifestyle, better results of Bioprosthetics as compared to
mechanical materials which were traditionally being used and extensive research
and innovations leading to multiple new avenues of use.
The intense competition is
keeping the key players at their toes. Extensive research and development
activities are being funded by the government and private companies to stay
afloat and ahead of everyone else. This has led to significant increase in
favorable R&D investment scenario. Companies are regularly rolling
out strategical developments to beat their competition keeping the market
lively and open. Nonetheless, many of the prosthesis-related complications,
choice of optimal prosthesis selection in the individual patient and careful
medical management and further follow-up after implantation can cause hindrance
in the growth of market during the forecast period. Moreover, patients with
prosthetic valves are at risk of thromboembolic complications, including
systemic embolization, most commonly cerebral, and prosthetic thrombosis
causing valve obstruction and/or regurgitation which are some of the major
market restraint for the market growth during the forecast period
To identify the key trends in
the industry, click on the link below:
No comments:
Post a Comment